BioCentury This Week
Skupno trajanje:
19 h 45 min
Ep. 293 - Tau Time for Alzheimer's. Plus: FDA Delays, Merck's $4B Deal, HK IPOs
BioCentury This Week
31:05
Ep. 292 - Myasthenia Gravis Spotlight & AACR Preview
BioCentury This Week
25:51
Ep. 291 - Grand Rounds - U.S. Preview
BioCentury This Week
31:02
Ep. 290 - Biotech Survey Sees Tough Days Ahead. Plus: FDA, China Speed
BioCentury This Week
38:10
Ep. 289 - Replacing Animal Models. Plus: RFK Jr. & FDA
BioCentury This Week
36:55
Ep. 288 - FDA and Tariffs Turmoil, and AACR Preview
BioCentury This Week
26:34
Ep. 287 - The Bear is Back: Marks’ Ouster, Tariffs and a Tumbling XBI
BioCentury This Week
25:46
Ep. 286 - Sofinnova’s Pan-European Accelerator, China Biotechs, Trump Tariffs
BioCentury This Week
24:30
Ep. 285 - BIO's Trump 2.0 Plan. Plus: Autoimmune CAR Ts & Telix's Radiopharma Play
BioCentury This Week
28:26
Ep. 284 - Takeaways from the East-West Summit
BioCentury This Week
41:27
Ep. 283 - Makary’s FDA Agenda, Amylin in Obesity and Life After DEI
BioCentury This Week
31:30
Ep. 282 - CRISPR Lessons: Plus, AbbVie Enters Obesity
BioCentury This Week
23:46
Ep. 281 - Roche Reboot and 5 Things on Trump 2.0
BioCentury This Week
22:12
Ep. 280 - China Competition. Plus: FDA Firings and Biotech IPOs
BioCentury This Week
27:52
Ep. 279 - East-West Summit Preview
BioCentury This Week
29:54
Ep. 278 - Trump 2.0’s Impact on FDA, NIH. Plus: Precision Medicine
BioCentury This Week
26:14
Ep. 277 - Asia's NewCo Model, FDA Tipping Point, Vertex's Pain Drug
BioCentury This Week
25:03
Ep. 276 - Precision Neuropsychiatry Spotlight With ICON's Peter Schueler
BioCentury This Week
21:07
Ep. 275 - Series As & Innovation. Plus: Rocky Transition at FDA, NIH
BioCentury This Week
33:09
Ep. 274 - 2025 Biotech Preview: Markets, Catalysts and AI
BioCentury This Week
36:21
Ep. 273 - JPM 2025 Wrap: Sunny Skies & Megarounds
BioCentury This Week
22:21
Ep. 272 - JPM Deal Buzz & Rep. Auchincloss’ Take on Biopharma
BioCentury This Week
27:29
Ep. 271 - Biotech in the New Year. Plus: Beyond Biosecure
BioCentury This Week
34:54
Ep. 270 - Temple’s FDA Legacy. Plus: Chinese Innovation & Novo Obesity Data
BioCentury This Week
34:56
Bonus Content - Trends in Global Biopharma Deals: Lazard’s Kingston and Raine
BioCentury This Week
34:54
Ep. 269 - Trends in VC Funds, Obesity Start-ups and More
BioCentury This Week
33:14
Ep. 268 - Biosecure Setback & Novartis' $1B PTC Deal
BioCentury This Week
21:49
Ep. 267 - Trump's NIH Pick & Multi-targeted CAR Ts
BioCentury This Week
27:26
Ep. 266 - Jefferies Recap, FDA Commissioner & Biosecure Update
BioCentury This Week
26:32
Ep. 265 - RFK Jr. & HHS, Blenrep's Comeback, China Deals
BioCentury This Week
29:42
Ep. 264 - Prepping for Trump & Alzheimer's Ethics
BioCentury This Week
29:10
Ep. 263 - Alzheimer Insights: Anti-Amyloid Safety & Tau Teaser
BioCentury This Week
34:38
Ep. 262 - EGFR Case Study, FDA & Politics
BioCentury This Week
23:38
Ep. 261 - China Summit: Reinventing Your China Strategy
BioCentury This Week
31:39
Ep. 260 - VC Funds, New Chapter for MS, Wave's Data
BioCentury This Week
31:18
Ep. 259 - Causal Biology and Big Data, Ultra-Rare Drugs at FDA
BioCentury This Week
33:50
Ep. 258 - Breaking the Bear: 4Q Public Markets Preview
BioCentury This Week
39:44
Ep. 257 - Schizophrenia, Sickle Cell Drugs, D.C. Update
BioCentury This Week
32:19
Ep. 256 - ESMO Recap: Keeping TIGIT Alive, Rybrevant & Immunotherapy Anniversary
BioCentury This Week
26:57
Ep. 255 - Pediatric PRVs, Biosecure & Novo's Obesity Miss
BioCentury This Week
21:49
